Glucocorticoids given systemically (in pill form) are more likely to be present at higher levels in maternal tissue than glucocorticoids applied topically. High-potency topical glucocorticoids used on large body areas over a period of time may affect maternal pituitary and adrenal hormone levels and may cross the placenta.